Valuation of research, transfer of technology

The protection of intellectual property as well as strong and lasting collaborations with industry are the necessary steps to transfer diagnostics and therapies from laboratories to patients.

The INMG relies on its supervisory services and on SATT Pulsalys to promote and transfer innovations from the laboratory.

The NeuroMyoGene Institute has laboratory surfaces dedicated to hosting for biotechnology companies and / or developing medical devices in its premises. Companies incubated or housed within the INMG thus have privileged access to an ecosystem of experts in the field of neuromuscular diseases, advanced technology platforms in the Rockefeller domain and a unique network of clinicians.

The INMG teams are also heavily involved in research consortia with companies and direct collaborations with industry.